Shuttle Pharmaceuticals Inc (SHPH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $21.58M
Last updated: Nov 17, 2026 at 4:10 PM ET
Shuttle Pharmaceuticals Inc (SHPH) Statistics
Shuttle Pharmaceuticals (SHPH) has a market cap of $21.58M and an enterprise value of $21.74M. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 0.74% above the market cap, as debt exceeds cash.
| Market Cap | $21.58M |
|---|---|
| Enterprise Value | $21.74M |
| Latest price (Nov 17, 2026) | $4.30 |
Key Dates
| Last Earnings Date | Sep 24, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
| P/B Ratio | 0.2x |
|---|---|
| P/TBV Ratio | 0.4x |
Price Statistics
The stock is down 81.47% over 52 weeks and trades 4.87% below its 50-day average.
| Beta (1Y) | 0.46 |
|---|---|
| 52-Week Change | -81.47% |
| 1-Month Change | -8.90% |
| 3-Month Change | +14.36% |
| 6-Month Change | -29.39% |
| Total Return (1Y) | -81.47% |
| Total Return (3Y CAGR) | -83.57% |
| Return vs SPY (1Y) | -91.18% |
| Max Drawdown (1Y) | -88.88% |
| Max Drawdown (3Y) | -99.76% |
| Sharpe Ratio (1Y) | -1.14 |
| Correlation with SPY (1Y) | 0.05 |
| 50-Day Average | $4.52 |
| 200-Day Average | $6.12 |
| 52-Week Range | $2.58 to $27.30 |
| RSI (14 Days) | 40.8 |
| Average Volume (20 Days) | 32.18K |
Financial Position
Current assets cover 0.11x current liabilities, and total debt is 0.01x shareholder equity.
| Current Ratio | 0.11x |
|---|---|
| Quick Ratio | 0.11x |
| Debt / Equity | 0.01x |
| Interest Coverage | 10.78x |
Returns and Efficiency
Return on invested capital is -45.97% and return on equity is -53.49% over the last 12 months.
| Return on Equity (ROE) | -53.49% |
|---|---|
| Return on Assets (ROA) | -44.98% |
| Return on Invested Capital (ROIC) | -45.97% |
Scores
SHPH has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$289.07K |
| Operating Income | -$11.22M |
| Pretax Income | -$10.26M |
| Net Income | -$10.26M |
| EBITDA | -$9.71M |
| Reported EPS (TTM) | -$22.09 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 84.09% of the $22.81M in total assets.
| Cash and Equivalents | $90.24K |
|---|---|
| Total Debt | $250.00K |
| Net Debt | $159.76K |
| Net Debt Per Share | $0.16 |
| Working Capital | -$3.08M |
| Shareholder Equity | $19.18M |
| Book Value Per Share | $18.90 |
| Tangible Book Value | $10.53M |
| Tangible Book Per Share | $10.38 |
| Total Assets | $22.81M |
| Total Liabilities | $3.63M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Operating Cash Flow | -$6.58M |
|---|---|
| FCF Per Share | -$1.39 |
| Depreciation and Amortization | $1.60M |
Trailing 12 months through Jun 30, 2026.
Dividends and Yields
SHPH does not pay a dividend.
| Buyback Yield | -124.69% |
|---|---|
| Shareholder Yield | -124.69% |
Stock Splits
The last split was a 1-for-10 reverse split on Jun 11, 2026.
| Last Split Date | Jun 11, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Peer Position
Against 6 similar companies, SHPH has the 5th highest ROIC.
ROICPeer median -17.27%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +3.38%
| ROIC | -45.97% vs -17.27% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs +3.38% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SHPH
What is SHPH's market cap?
Shuttle Pharmaceuticals has a market cap of $21.58M. Its enterprise value, which adds debt and subtracts cash, is $21.74M.
How many shares of SHPH are outstanding?
Shuttle Pharmaceuticals has 1.02M shares outstanding.
Does SHPH pay a dividend?
No. Shuttle Pharmaceuticals does not pay a dividend.
How much debt does SHPH have?
Shuttle Pharmaceuticals has $250.00K of total debt and $90.24K of cash and equivalents, a net debt position of $159.76K.
SHPH pages: Overview, Charting, Financials, Statistics, Competitors